Determinants of, and outcomes associated with, antihypertensive-associated incident diabetes and metabolic syndrome in hypertensive patients in the ASCOT-trial
Controversy exists whether the adverse effects on glucose metabolism and the increased incidence of new‐onset diabetes (NOD) associated with beta‐blockers and/or diuretics translate into adverse cardiovascular (CV) events, and thereby seriously detract from the beneficial effects of the these agents...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2012
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.560643 |